Takeda: Hyperlipidemias trials

The registry lists 21 Hyperlipidemias studies with Takeda as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 2 3Phase 3 14Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the BloodCompletedNCT02839902Phase 4Results posted
• Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated DilationCompletedNCT02824432Phase 4Results posted
• Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3CompletedNCT02285166Results posted
• Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl EstersCompletedNCT02153073Results posted
• Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.CompletedNCT00770653Phase 3Results posted
• Safety of Lapaquistat Acetate in Subjects With HypercholesterolemiaCompletedNCT00868127Phase 3
• Efficacy of Lapaquistat Acetate in Subjects With HypercholesterolemiaTerminatedNCT00865228Phase 2
• Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With HypercholesterolemiaCompletedNCT00864643Phase 2
• Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol LevelsCompletedNCT00813527Phase 2
• Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With HypercholesterolemiaTerminatedNCT00532558Phase 3
• Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With HypercholesterolemiaTerminatedNCT00532311Phase 3
• Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary DyslipidemiaCompletedNCT00487994Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With HypercholesterolemiaCompletedNCT00286481Phase 3
• Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.CompletedNCT00268697Phase 3
• Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial HypercholesterolemiaTerminatedNCT00263081Phase 3
• Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.CompletedNCT00256178Phase 3
• Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.CompletedNCT00251680Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With HypercholesterolemiaCompletedNCT00249912Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With HypercholesterolemiaTerminatedNCT00249899Phase 3
• Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary HypercholesterolemiaCompletedNCT00143676Phase 3
• Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated CholesterolCompletedNCT00143663Phase 3